ST. LOUIS, Oct. 21, 2025 /PRNewswire/ -- Codis, a global CDMO specializing in commercial spray drying, amorphous solid dispersions (ASD), and particle engineering technologies, has appointed Steven ...
With this acquisition, Codis becomes a leading provider of end-to-end spray dry solutions in EuropeNottingham adds oral solid dose development and small-scale commercial manufacturing with over ...
"Codis is built on a foundation of scale, quality, and global reach," said Nicolas Fortin, Codis CEO. "With a total of 40,000 m 2 of manufacturing space, three GMP facilities and with 7 of regulatory ...
ST. LOUIS, March 4, 2026 /PRNewswire/ -- Codis, a global contract development and manufacturing organization (CDMO) specializing in spray drying, amorphous solid dispersions (ASDs), and advanced ...
Codis is acquiring Catalent Pharma Solutions’ Nottingham, UK facility, which will help expand Codis’ spray drying ...
Use of proceeds: Expand Haverhill, UK commercial manufacturing capacity Current scale: More than 400,000 square feet across three cGMP sites (US and UK); >5,000 MT/year spray-dried capacity ST. LOUIS, ...
The MarketWatch News Department was not involved in the creation of this content. New global CDMO combines commercial spray drying and particle engineering technologies under one brand. -- Codis ...
This investment is supported by the UK government's Life Sciences Innovative Manufacturing Fund (LSIMF), subject to final agreement of terms and conditions, which offers up to £520 million in capital ...
Codis appoints Steven Facer as Senior VP Sales & Marketing, bringing over 30 years of international pharmaceutical leadership experience. Proven track record at Adare, Thermo Fisher, Capsugel and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results